University Of California, Davis

This study tested whether combining two existing drugs, lenalidomide and rituximab, could effectively treat adults with a slow-growing type of non-Hodgkin's lymphoma who had not received any prior treatment. The goal was to see if this drug combination could shrink tumors and con…